Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.
2.

Variability of osp genes and gene products among species of Lyme disease spirochetes.

Marconi RT, Konkel ME, Garon CF.

Infect Immun. 1993 Jun;61(6):2611-7.

3.
4.

Immunological and molecular polymorphisms of OspC, an immunodominant major outer surface protein of Borrelia burgdorferi.

Wilske B, Preac-Mursic V, Jauris S, Hofmann A, Pradel I, Soutschek E, Schwab E, Will G, Wanner G.

Infect Immun. 1993 May;61(5):2182-91.

5.

In vitro inhibition of Borrelia burgdorferi growth by antibodies.

Sadziene A, Thompson PA, Barbour AG.

J Infect Dis. 1993 Jan;167(1):165-72.

PMID:
8418163
6.

Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA.

Erdile LF, Brandt MA, Warakomski DJ, Westrack GJ, Sadziene A, Barbour AG, Mays JP.

Infect Immun. 1993 Jan;61(1):81-90.

7.

The 39-kilodalton protein of Borrelia burgdorferi: a target for bactericidal human monoclonal antibodies.

Scriba M, Ebrahim JS, Schlott T, Eiffert H.

Infect Immun. 1993 Oct;61(10):4523-6.

8.

Seroprotective groups among isolates of Borrelia burgdorferi.

Lovrich SD, Callister SM, Lim LC, Schell RF.

Infect Immun. 1993 Oct;61(10):4367-74.

10.

Distinct patterns of protective antibodies are generated against Borrelia burgdorferi in mice experimentally inoculated with high and low doses of antigen.

Schaible UE, Gern L, Wallich R, Kramer MD, Prester M, Simon MM.

Immunol Lett. 1993 May;36(2):219-26.

PMID:
8349316
11.

Protection against antigenically variable Borrelia burgdorferi conferred by recombinant vaccines.

Telford SR 3rd, Fikrig E, Barthold SW, Brunet LR, Spielman A, Flavell RA.

J Exp Med. 1993 Aug 1;178(2):755-8.

12.

Performance of a Borrelia burgdorferi bacterin in borreliosis-endemic areas.

Levy SA, Lissman BA, Ficke CM.

J Am Vet Med Assoc. 1993 Jun 1;202(11):1834-8.

PMID:
8320151
13.

Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.

Stover CK, Bansal GP, Hanson MS, Burlein JE, Palaszynski SR, Young JF, Koenig S, Young DB, Sadziene A, Barbour AG.

J Exp Med. 1993 Jul 1;178(1):197-209.

14.

Current understanding of Borrelia burgdorferi infection, with emphasis on its prevention in dogs.

Kazmierczak JJ, Sorhage FE.

J Am Vet Med Assoc. 1993 Dec 1;203(11):1524-8. Review. No abstract available.

PMID:
8288471
15.

Protective immunity is induced by a Borrelia burgdorferi mutant that lacks OspA and OspB.

Hughes CA, Engstrom SM, Coleman LA, Kodner CB, Johnson RC.

Infect Immun. 1993 Dec;61(12):5115-22.

17.

Ability of canine Lyme disease vaccine to protect hamsters against infection with several isolates of Borrelia burgdorferi.

Jobe DA, Callister SM, Lim LC, Lovrich SD, Schell RF.

J Clin Microbiol. 1994 Mar;32(3):618-22.

18.

Detection of borreliacidal antibody by using acridine orange and flow cytometry.

Lim LC, Liu YF, Schell K, Lovrich SD, Callister SM, Schell RF.

Clin Diagn Lab Immunol. 1994 Jan;1(1):44-50.

19.

Lyme disease-a tick-borne spirochetosis?

Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP.

Science. 1982 Jun 18;216(4552):1317-9.

PMID:
7043737
20.

The early clinical manifestations of Lyme disease.

Steere AC, Bartenhagen NH, Craft JE, Hutchinson GJ, Newman JH, Rahn DW, Sigal LH, Spieler PN, Stenn KS, Malawista SE.

Ann Intern Med. 1983 Jul;99(1):76-82.

PMID:
6859726
Items per page

Supplemental Content

Write to the Help Desk